Results 291 to 300 of about 29,115,033 (392)

Rapid sequence induction with target‐controlled infusions: a technical simulation study

open access: yes
Anaesthesia, EarlyView.
Andrea Gentile   +3 more
wiley   +1 more source

Inter‐rater reliability of the Team Formulation Quality Rating Scale (TFQS) in inpatient mental health teams

open access: yesBritish Journal of Clinical Psychology, EarlyView.
Abstract Objectives Team formulation is associated with better working relationships between staff and service users. However, there is a need for greater standardization of practice. We aimed to investigate the inter‐rater reliability of the Team Formulation Quality Rating Scale (TFQS) and explore what aspects of team formulation practices were most ...
Joshua Eli Thompson   +3 more
wiley   +1 more source

Guideline of guidelines: management of small testicular masses

open access: yesBJU International, EarlyView.
Objective To compare and summarise the most up to date international guidelines and major recommendations for the management of small testicular masses (STMs). Methods A systematic search was conducted in PubMed, EMBASE, Scopus, Google Scholar, and the Cochrane Library up to 1 November 2024.
Marco Tozzi   +7 more
wiley   +1 more source

The Recruitment and Retention of Individuals With Intellectual Disability in Randomized Controlled Trials: A Scoping Review

open access: yesBritish Journal of Learning Disabilities, EarlyView.
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody   +5 more
wiley   +1 more source

Recurrence of Dupuytren\u27s contracture: A consensus-based definition [PDF]

open access: yes, 2017
Dupuytren Delphi Group,   +6 more
core   +1 more source

Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC‐2

open access: yesClinical &Experimental Allergy, EarlyView.
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy